These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7302901)

  • 21. Immunoreactivity of cross-linked fibrin derivatives (D-dimer) and monoclonal antibodies.
    Rylatt D; Bundesen P
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):365. PubMed ID: 8735147
    [No Abstract]   [Full Text] [Related]  

  • 22. An immunoassay for human D dimer using monoclonal antibodies.
    Rylatt DB; Blake AS; Cottis LE; Massingham DA; Fletcher WA; Masci PP; Whitaker AN; Elms M; Bunce I; Webber AJ
    Thromb Res; 1983 Sep; 31(6):767-78. PubMed ID: 6359576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybridoma Technology.
    Hnasko RM; Stanker LH
    Methods Mol Biol; 2015; 1318():15-28. PubMed ID: 26160560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.
    Sola B; Avner PR; Zilber MT; Connan F; Lévy D
    Thromb Res; 1983 Mar; 29(6):643-53. PubMed ID: 6857603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies.
    Halabi G; McCullough KC
    J Immunol Methods; 1995 Oct; 186(2):205-16. PubMed ID: 7594620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics.
    Kulshreshtha P; Tiwari A; Priyanka ; Joon S; Sinha S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):185-93. PubMed ID: 26364143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A neoantigenic determinant in the D-dimer fragment of fibrin.
    Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation and characterization of the monoclonal antibody against HIV-1 p24 antigen].
    Hou J; Hu Y; Zhu L; Shen HH; Yang JY; Hong SW; Mao PY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):699-701. PubMed ID: 15555439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunoassay of fibrinogen-fibrin degradation products: assay for fragment E-related neoantigen-methodological aspects.
    Chen JP; Schulof RS
    Thromb Res; 1979; 16(5-6):601-15. PubMed ID: 93312
    [No Abstract]   [Full Text] [Related]  

  • 34. [Morphocytochemical and electron microscopic research on murine hybridoma cells producing and not producing monoclonal antibodies].
    Sidorenko SP; Gluzman DF; Vetrova EP; Iurchenko OV; Berdova AG
    Tsitologiia; 1988 Jan; 30(1):39-43. PubMed ID: 3358281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal Antibody Against Human GLRX3.
    Monoclon Antib Immunodiagn Immunother; 2016 Dec; 35(6):309. PubMed ID: 28029331
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preparation and characterization of McAbs against the human crosslinked fibrin degradation product D-dimer].
    Qi G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Oct; 13(5):313-6. PubMed ID: 1839247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA.
    Velikovsky CA; Cassataro J; Sanchez M; Fossati CA; Fainboim L; Spitz M
    J Immunol Methods; 2000 Oct; 244(1-2):1-7. PubMed ID: 11033013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making monoclonal antibodies.
    Asai DJ; Wilder JK
    Methods Cell Biol; 1993; 37():57-74. PubMed ID: 8255250
    [No Abstract]   [Full Text] [Related]  

  • 39. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte.
    Miyahara M; Nakamura H; Hamaguchi Y
    Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
    Gargan PE; Ploplis VA; Scheu JD
    Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.